In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine have found that the anti-depressant drug fluvoxamine seems to prevent some of the most serious complications of the illness, and makes hospitalization and the need for supplemental oxygen less likely.
Anti-Depressant may help treat COVID-19
![FLUVOXAMINE—SHOWN IN THE MOLECULAR FORMULA](https://icts.wustl.edu/wp-content/uploads/2021/03/bench_shutterstock_570961492_Vi-1024x567.jpg)
View Content